Dermatological Nd:YAG/frequency-doubled Nd:YAG laser system - Dermatological Nd:YAG/frequency-doubled Nd:YAG laser system - ARTG 351591
Access comprehensive regulatory information for Dermatological Nd:YAG/frequency-doubled Nd:YAG laser system - Dermatological Nd:YAG/frequency-doubled Nd:YAG laser system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 351591 and sponsored by Cutera Australia Pty Ltd, manufactured by Cutera Inc in United States of America. The device registration started on December 10, 2020.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
Intended for use in medical and cosmetic procedures in the specialties of dermatology, plastic surgery, and aesthetic medicine. Specific indications: -Treatment of benign vascular lesions including, but not limited to, telangiectasia, angiomas, port wine stains, diffuse redness, poikiloderma of civatte, rosacea, leg veins, periocular veins, venous lakes, and hemangiomas -Treatment of benign pigmented lesions including, but not limited to, senile and solar lentigines, dermatosis papulose nigra, ephelides, dyschromia, and nevi -Treatment of benign cutaneous lesions including, but not limited to, wrinkles, verrucae, seborrheic keratoses, acne scars, skin tags, erythematous scars, bruising, and mild to moderate acne vulgaris -Hair removal -Treatment of pseudofolliculitis barbae